The current status of HPV DNA testing

Area of Science:

• Oncology
• Virology
• Gynecology

Background:

• High-risk human papillomavirus (HPV) infection is the primary cause of cervical intraepithelial neoplasia (CIN) and cervical cancer.
• Current detection methods for cervical HPV DNA include PCR and molecular hybridization.
• HPV testing is being investigated for cervical neoplasia screening, triage of low-grade lesions, and post-treatment follow-up.

Purpose of the Study:

• To evaluate the utility of HPV DNA testing in different clinical applications for cervical cancer management.
• To assess the effectiveness of HPV testing in screening, triage, and follow-up scenarios.

Main Methods:

• Review of research focusing on HPV testing applications in cervical neoplasia.
• Analysis of data from randomized studies and observational studies on HPV DNA detection.

Main Results:

• HPV testing may not offer advantages over cytology for general screening due to false positives in younger women, but is valuable for middle-aged women and in low-resource settings.
• HPV testing can aid in triaging women with ASCUS (atypical squamous cells of undetermined significance), guiding colposcopy referral when high-risk HPV DNA is detected.
• Observational data suggest HPV DNA testing is sensitive for detecting residual or recurrent CIN after conservative surgical treatment.

Conclusions:

• HPV testing has specific roles in cervical cancer management, particularly in triage and post-treatment surveillance.
• Its application in general screening is limited, but it holds value in specific populations and settings.
• Further research, including randomized controlled trials, is needed to solidify its role in certain applications.